Form 4: HCA Healthcare Director Equity Award Filing

Director Nancy-Ann DeParle received an annual equity grant of 509 restricted share units in HCA Healthcare, Inc.

Summary

• Nancy-Ann DeParle, a Director at HCA Healthcare, Inc., was granted 509 restricted share units (RSUs) on April 28, 2026.
• The grant represents an annual director equity award.
• Following this transaction, the reporting person's total beneficial ownership of HCA common stock is 21,910 shares.
• The RSUs are scheduled to vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The equity grant aligns the interests of the director with those of the shareholders by increasing her equity stake in the company.

Negatives

• None identified.

Risks

• The value of the equity award is subject to market fluctuations in HCA Healthcare's common stock price.

Future Outlook

The restricted share units are expected to vest by the 2027 annual shareholders' meeting or the first anniversary of the grant date, whichever occurs first.

Industry Context

StockSavvy.ai notes that annual equity grants for board members are standard corporate governance practice in the healthcare sector to ensure long-term alignment between leadership and shareholder interests.

Comparison to Industry Standards

• The issuance of restricted share units as part of director compensation is consistent with standard practices for large-cap healthcare companies like HCA Healthcare.
• The vesting schedule is typical for annual director equity awards in the S&P 500.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard, expected component of director compensation.

Next Steps

• Vesting of the 509 restricted share units by the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Key Dates

Keywords

HCA Healthcare, Director, Equity Award, Form 4, Insider Transaction, Restricted Share Units